Liver Cancer Treatment Using Surefire Technology Leads to 92% Objective Response Rate
Surefire Medical revealed at the Cardiovascular and Interventional Radiological Society of Europe Annual Scientific Congress the results of a multi-center registry in which the use of the Surefire Precision Infusion System to deliver therapy in the treatment of primary liver cancer (hepatocellular carcinoma or HCC) was associated with a 68 percent complete tumor response and 92 percent objective tumor response.
According to a release, the multi-center registry evaluated the use of Surefire Precision during transarterial chemoembolization (TACE) in 32 patients with 41 lesions. Among the institutions included in the study were Mt. Sinai Hospital, Piedmont Hospital, University of Southern California Medical Center, Georgetown University via MedStar Georgetown University Hospital, and the University of California at San Diego Medical Center.
"TACE procedures utilizing the Surefire Infusion System was shown to effectively deliver therapy to the tumor," said Aravind Arepally, MD, Chief Scientific Officer for Surefire Medical. "The objective response rate shown in this multi-center registry is considerably higher when compared to the average response rate we see in the literature."
Surefire Medical is also conducting a 140-patient, randomized controlled, multi-center study comparing the outcomes of Surefire to standard end-hole catheter for drug-eluting beads transarterial chemoembolization (DEB-TACE) treatments in HCC. The study, titled "Surefire vs. Endhole for DEB-TACE: Quantifying Hepatic Artery Embolization to Improve Outcomes," is currently enrolling patients and seeking new sites.
((Comments on this story may be sent to email@example.com))
THE DAILY VIEW
Tea Forté Introduces ‘Matcha’ Collection
Convenience meets tradition in Tea Forté’s new Ceremonial Matcha Bowl Set and the Matcha Single Steeps.
The company said its spring harvested, shade grown, stone ground, organic matcha tea is best served in a centuries-old Japanese tea ceremony called chanoyu: a preparation technique known for its centering meditative qualities.
"The launch of Tea Forté's Matcha collection represents our continued commitment to wellness and cultivating all the potential mental and physical health benefits of tea," says Tea Forté CEO Michael Gebrael. "In addition to our high quality Pure Matcha, we've also blended four distinct flavored Matcha varieties. Prepackaged in pouches measured out for a single serving, our Single Steeps Matcha is ideal for the office, travel, or to keep with you for a boost anytime."
Tea Forté noted its handcrafted ceremonial tea bowl, handmade bamboo whisk and measuring ladle “encourages serene enjoyment of our premium Kosher, gluten-free and vegan matcha blends.” These include: Pure Matcha, Chocolate Matcha, Coconut Matcha, Ginger Matcha, and Chai Matcha.
According to a release, in addition to its distinctive taste, matcha is prized for its health benefits. Steeped green tea contains only the antioxidants that can be extracted in water, while with matcha, the whole leaf is consumed.
Available now in select stores and online at teaforte.com.
Expedia.com has released a year-end look at U.S. traveler behavior and trends for 2017, analyzing data to identify the most in-demand destinations, hotels, activities and more.
Among other insights, the roundup revealed:
- Labor Day was the busiest weekend for car rental
- Disney Theme Parks topped the list of things to do
- The average hotel stay was two nights
- Top destinations based on 2017 air travel included major global cities like New York, London and Bangkok
- Popular tourist destinations included Orlando, Cancun and Las Vegas